Literature DB >> 2817601

Pleural fibrinolytic activity is decreased in inflammation as demonstrated in quinacrine pleurodesis treatment of malignant pleural effusion.

V Agrenius1, J Chmielewska, O Widström, M Blombäck.   

Abstract

Chronic malignant pleural exudation is generally characterized by little or no fibrin deposition. However, during induced inflammation, fibrin deposition concomitant with cessation of exudation is seen. To judge the involvement of the fibrinolytic system in this process, concentrations of fibrinolytic factors were followed in 10 patients during treatment by quinacrine instillation and tube drainage. Plasminogen and alpha-2-antiplasmin were found in low concentrations and did not show significant changes during treatment. The plasminogen activator inhibitor PAI-1, which plays an important role in the regulation of fibrinolysis, was also studied during treatment. Before treatment the concentration of PAI-1 was 21.7 +/- 12.0 (mean +/- SD) AU/ml and it increased to 86.9 +/- 25.9 AU/ml 6 h after quinacrine instillation. D-dimer, a product of the lysis of fibrin, was found in high concentrations before treatment (62.7 +/- 25.5 micrograms/ml) and in low concentrations 6 h after treatment (12.2 +/- 7.9 micrograms/ml). Thus, it was possible to demonstrate that the fibrinolytic system is activated during chronic malignant pleural exudation and, furthermore, that the activity decreases during induced inflammation.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2817601     DOI: 10.1164/ajrccm/140.5.1381

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  7 in total

1.  Insulin acts through FOXO3a to activate transcription of plasminogen activator inhibitor type 1.

Authors:  Ushma R Jag; Jiri Zavadil; Frederick M Stanley
Journal:  Mol Endocrinol       Date:  2009-07-16

2.  Decreased proinflammatory cytokines production in children with complicated parapneumonic pleural effusion after intrapleural fibrinolytic treatment.

Authors:  Jieh-Neng Wang; Jyh-Wei Shin; Tsuey-Yu Chang; Jiu-Yao Wang; Jing-Ming Wu
Journal:  Inflammation       Date:  2009-12       Impact factor: 4.092

3.  Lung abscess predicts the surgical outcome in patients with pleural empyema.

Authors:  Hung-Che Huang; Heng-Chung Chen; Hsin-Yuan Fang; Yi-Chieh Lin; Chin-Yen Wu; Ching-Yuan Cheng
Journal:  J Cardiothorac Surg       Date:  2010-10-20       Impact factor: 1.637

4.  Role of talc modulation on cytokine activation in cancer patients undergoing pleurodesis.

Authors:  Yehuda Schwarz; Alex Star
Journal:  Pulm Med       Date:  2012-03-07

Review 5.  Chemical pleurodesis - a review of mechanisms involved in pleural space obliteration.

Authors:  Michal Mierzejewski; Piotr Korczynski; Rafal Krenke; Julius P Janssen
Journal:  Respir Res       Date:  2019-11-07

6.  Does the evaluation of coagulation factors contribute to etiological diagnosis of pleural effusions?

Authors:  Marcelo Alexandre Costa Vaz; Francisco Suso Vargas; Felipe Costa de Andrade Marinho; Elbio Antonio D'Amico; Tânia Rubia Flores Rocha; Lisete Ribeiro Teixeira
Journal:  Clinics (Sao Paulo)       Date:  2009       Impact factor: 2.365

7.  Pleural Fluid Cytokine Levels at Baseline and Over Time are Associated With Time to IPC Removal: An Exploratory Study.

Authors:  Horiana B Grosu; Wei Lu; David E Ost; Macarena R Vial; Mike Hernandez; Natasha Ghosh; Laila Noor; Arain M Hasan; Lara Bashoura; Saadia Faiz; Dave Balachandran; Roberto Casal; George Eapen; Vickie Shannon; Ajay Sheshadri; Ximing Tang; Najib Rahman; Ignacio I Wistuba
Journal:  J Bronchology Interv Pulmonol       Date:  2020-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.